VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 98 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -33.3% | 150 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | -62.5% | 150 | -62.5% | 0.00% | -100.0% |
Q1 2019 | $8,000 | +33.3% | 400 | -38.5% | 0.00% | – |
Q4 2018 | $6,000 | -50.0% | 650 | 0.0% | 0.00% | – |
Q3 2018 | $12,000 | -7.7% | 650 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $13,000 | +8.3% | 650 | -13.3% | 0.00% | 0.0% |
Q1 2018 | $12,000 | 0.0% | 750 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $12,000 | -7.7% | 750 | +15.4% | 0.00% | 0.0% |
Q3 2017 | $13,000 | +62.5% | 650 | +62.5% | 0.00% | 0.0% |
Q1 2016 | $8,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |